Humans, like many other species, regulate protein intake more strongly than any other dietary component and so if protein is diluted there is a compensatory increase in food intake. The hypothesis proposes that the dilution ...
Sep 3, 2023
3
308
Research led by the Department of Anthropology and School of Biomedical Sciences, Kent State University, Ohio, has investigated neuropeptide Y innervation in an area of the brain called the nucleus accumbens of various primate ...
Based on cues she'd picked up from popular culture and public health guidance, Stanford Medicine statistician Maya Mathur, Ph.D., had always assumed that being overweight decreases lifespans. She was surprised, then, to come ...
Sep 8, 2023
2
114
Disrupted connections between memory and appetite regulating brain circuits are directly proportional to body mass index (BMI), notably in patients who suffer from disordered or overeating that can lead to obesity, such as ...
Aug 30, 2023
0
66
People who have watched repeated immersive videos of others consuming candy, subsequently have a significantly decreased craving for it, a team of scientists from Nanyang Technological University, Singapore (NTU Singapore) ...
Aug 28, 2023
0
171
A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024—subject to availability.
Sep 15, 2023
0
5
In a significant development that brings hope to the one billion individuals with obesity worldwide, researchers led by Director C. Justin Lee from the Center for Cognition and Sociality (CCS) within the Institute for Basic ...
Aug 31, 2023
1
13
With three-quarters of Americans obese or overweight, interest in weight-loss treatments is at an all-time high. Three injectable medications have dominated the spotlight of late: Wegovy, Ozempic and Mounjaro. These once-a-week, ...
Sep 8, 2023
0
1
The weight-loss jab Wegovy has been hailed as an "absolute game-changer" after a new study showed that it relieved symptoms and improved the quality of life in people with a common form of heart failure.
Sep 1, 2023
0
6
In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a "gamechanger." Gamechanger is a word used far too often by journalists to describe ...
Sep 6, 2023
0
1
